288 related articles for article (PubMed ID: 34197875)
1. Suppressor of cytokine signalling-2 controls hepatic gluconeogenesis and hyperglycemia by modulating JAK2/STAT5 signalling pathway.
Zhang X; Zhuang Y; Qin T; Chang M; Ji X; Wang N; Zhang Z; Zhou H; Wang Q; Li JZ
Metabolism; 2021 Sep; 122():154823. PubMed ID: 34197875
[TBL] [Abstract][Full Text] [Related]
2. PPP1R3C mediates metformin-inhibited hepatic gluconeogenesis.
Ji X; Wang S; Tang H; Zhang Y; Zhou F; Zhang L; Zhu Q; Zhu K; Liu Q; Liu Y; Wang X; Zhou L
Metabolism; 2019 Sep; 98():62-75. PubMed ID: 31181215
[TBL] [Abstract][Full Text] [Related]
3. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
[TBL] [Abstract][Full Text] [Related]
4. Orphan nuclear receptor small heterodimer partner negatively regulates growth hormone-mediated induction of hepatic gluconeogenesis through inhibition of signal transducer and activator of transcription 5 (STAT5) transactivation.
Kim YD; Li T; Ahn SW; Kim DK; Lee JM; Hwang SL; Kim YH; Lee CH; Lee IK; Chiang JY; Choi HS
J Biol Chem; 2012 Oct; 287(44):37098-108. PubMed ID: 22977252
[TBL] [Abstract][Full Text] [Related]
5. Role of KLF15 in regulation of hepatic gluconeogenesis and metformin action.
Takashima M; Ogawa W; Hayashi K; Inoue H; Kinoshita S; Okamoto Y; Sakaue H; Wataoka Y; Emi A; Senga Y; Matsuki Y; Watanabe E; Hiramatsu R; Kasuga M
Diabetes; 2010 Jul; 59(7):1608-15. PubMed ID: 20393151
[TBL] [Abstract][Full Text] [Related]
6. SOCS2 exacerbates myocardial injury induced by ischemia/reperfusion in diabetic mice and H9c2 cells through inhibiting the JAK-STAT-IGF-1 pathway.
Sheng M; Huang Z; Pan L; Yu M; Yi C; Teng L; He L; Gu C; Xu C; Li J
Life Sci; 2017 Nov; 188():101-109. PubMed ID: 28867579
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B
Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967
[No Abstract] [Full Text] [Related]
8. The Hypoglycemic Effect of Berberine and Berberrubine Involves Modulation of Intestinal Farnesoid X Receptor Signaling Pathway and Inhibition of Hepatic Gluconeogenesis.
Sun R; Kong B; Yang N; Cao B; Feng D; Yu X; Ge C; Feng S; Fei F; Huang J; Lu Z; Xie Y; Yang CS; Guo GL; Wang G; Aa J
Drug Metab Dispos; 2021 Mar; 49(3):276-286. PubMed ID: 33376148
[TBL] [Abstract][Full Text] [Related]
9. Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis.
Lee YS; Lee EK; Oh HH; Choi CS; Kim S; Jun HS
J Diabetes Res; 2014; 2014():961732. PubMed ID: 25610880
[TBL] [Abstract][Full Text] [Related]
10. SOCS2: inhibitor of JAK2V617F-mediated signal transduction.
Quentmeier H; Geffers R; Jost E; Macleod RA; Nagel S; Röhrs S; Romani J; Scherr M; Zaborski M; Drexler HG
Leukemia; 2008 Dec; 22(12):2169-75. PubMed ID: 18769447
[TBL] [Abstract][Full Text] [Related]
11. SOCS2 inhibits hepatoblastoma metastasis via downregulation of the JAK2/STAT5 signal pathway.
Lv Y; Xie X; Zou G; Kong M; Yang J; Chen J; Xiang B
Sci Rep; 2023 Dec; 13(1):21814. PubMed ID: 38071211
[TBL] [Abstract][Full Text] [Related]
12. Myricitrin Ameliorates Hyperglycemia, Glucose Intolerance, Hepatic Steatosis, and Inflammation in High-Fat Diet/Streptozotocin-Induced Diabetic Mice.
Kim DY; Kim SR; Jung UJ
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182914
[TBL] [Abstract][Full Text] [Related]
13. Hepatic cytokine-inducible SH2-containing protein (CISH) regulates gluconeogenesis via cAMP-responsive element binding protein (CREB).
Xiao F; Deng J; Jiao F; Hu X; Jiang H; Yuan F; Chen S; Niu Y; Jiang X; Guo F
FASEB J; 2022 Oct; 36(10):e22541. PubMed ID: 36083102
[TBL] [Abstract][Full Text] [Related]
14. Effects of eugenol on hepatic glucose production and AMPK signaling pathway in hepatocytes and C57BL/6J mice.
Jeong KJ; Kim DY; Quan HY; Jo HK; Kim GW; Chung SH
Fitoterapia; 2014 Mar; 93():150-62. PubMed ID: 24418657
[TBL] [Abstract][Full Text] [Related]
15. Supplementation of persimmon leaf ameliorates hyperglycemia, dyslipidemia and hepatic fat accumulation in type 2 diabetic mice.
Jung UJ; Park YB; Kim SR; Choi MS
PLoS One; 2012; 7(11):e49030. PubMed ID: 23145054
[TBL] [Abstract][Full Text] [Related]
16. Baicalin ameliorates hepatic insulin resistance and gluconeogenic activity through inhibition of p38 MAPK/PGC-1α pathway.
Fang P; Sun Y; Gu X; Shi M; Bo P; Zhang Z; Bu L
Phytomedicine; 2019 Nov; 64():153074. PubMed ID: 31473580
[TBL] [Abstract][Full Text] [Related]
17. Citrus unshiu peel extract ameliorates hyperglycemia and hepatic steatosis by altering inflammation and hepatic glucose- and lipid-regulating enzymes in db/db mice.
Park HJ; Jung UJ; Cho SJ; Jung HK; Shim S; Choi MS
J Nutr Biochem; 2013 Feb; 24(2):419-27. PubMed ID: 22694954
[TBL] [Abstract][Full Text] [Related]
18. The hepatic FOXQ1 transcription factor regulates glucose metabolism in mice.
Cui Y; Qiao A; Jiao T; Zhang H; Xue Y; Zou Y; Cui A; Fang F; Chang Y
Diabetologia; 2016 Oct; 59(10):2229-39. PubMed ID: 27421728
[TBL] [Abstract][Full Text] [Related]
19. Insulin-Inducible SMILE Inhibits Hepatic Gluconeogenesis.
Lee JM; Seo WY; Han HS; Oh KJ; Lee YS; Kim DK; Choi S; Choi BH; Harris RA; Lee CH; Koo SH; Choi HS
Diabetes; 2016 Jan; 65(1):62-73. PubMed ID: 26340929
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-β induces hepatic insulin resistance by activating JAK2/STAT3/SOCS-1 signaling pathway.
Zhang Y; Zhou B; Zhang F; Wu J; Hu Y; Liu Y; Zhai Q
Diabetes; 2012 Jun; 61(6):1434-43. PubMed ID: 22522613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]